Processing of primary brain tumor tissue for stem cell assays and flow sorting.
Brain tumors are typically comprised of morphologically diverse cells that express a variety of neural lineage markers. Only a relatively small fraction of cells in the tumor with stem cell properties, termed brain tumor initiating cells (BTICs), possess an ability to differentiate along multiple lineages, self-renew, and initiate tumors in vivo. We applied culture conditions originally used for normal neural stem cells (NSCs) to a variety of human brain tumors and found that this culture method specifically selects for stem-like populations. Serum-free medium (NSC) allows for the maintenance of an undifferentiated stem cell state, and the addition of bFGF and EGF allows for the proliferation of multi-potent, self-renewing, and expandable tumorspheres. To further characterize each tumor's BTIC population, we evaluate cell surface markers by flow cytometry. We may also sort populations of interest for more specific characterization. Self-renewal assays are performed on single BTICs sorted into 96 well plates; the formation of tumorspheres following incubation at 37 °C indicates the presence of a stem or progenitor cell. Multiple cell numbers of a particular population can also be sorted in different wells for limiting dilution analysis, to analyze self-renewal capacity. We can also study differential gene expression within a particular cell population by using single cell RT-PCR. The following protocols describe our procedures for the dissociation and culturing of primary human samples to enrich for BTIC populations, as well as the dissociation of tumorspheres. Also included are protocols for staining for flow cytometry analysis or sorting, self-renewal assays, and single cell RT-PCR.
Stem Cell and Cancer Research Institute, McMaster University.
Chitra
C
Venugopal
Nicole M
NM
McFarlane
Sara
S
Nolte
Branavan
B
Manoranjan
Sheila K
SK
Singh
D001932:Brain Neoplasms / Q000235:genetics / Q000473:pathology*; D005434:Flow Cytometry / Q000379:methods*; D020869:Gene Expression Profiling; D006801:Humans; D014411:Neoplastic Stem Cells / Q000473:pathology* / Q000502:physiology; D014410:Tumor Stem Cell Assay / Q000379:methods*